Search
Home
next
About Us
next
Products
next
Customer Service
Investors
next
Careers
next
Worldwide Sites
Contact Us
Sitemap
About Us
About Taro Canada
Company History
Company Mission
Generic Drugs
Worldwide Sites
FAQ about Generics
Products
Taro
TaroPharma
Customer Service
Customer Service
Contact Us
Report Adverse Event
Careers
Overview
Job Postings
Accessibility
Total Rewards
Location
Worldwide Sites
Taro U.S.A
Taro Canada
Taro Israel
Taro International
Sun Pharma
Sun Pharmaceutical USA
Sun Pharmaceutical Europe
Chattem Chemicals Inc.
English
Français
a SUN PHARMA Company
Menu
HOME
Worldwide sites
Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Taro International
Sun Pharma
Sun Pharmaceutical USA
Sun Pharmaceutical Europe
Chattem Chemicals Inc.
English
Français
Products
Taro
TaroPharma
Search
Search form
Search
NOUVELLES
Toggle navigation
Customer Service
Report Adverse Event
Print
Maintenant offert, Taro-DOXOrubicin Liposomal, un générique de substitution à CAELYX®
Release Date:
Monday, May 25, 2020
Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
